timoh, I think that's got the chance to be a by-product of the...

timoh, I think that's got the chance to be a by-product of the various trials in that
"efti" if proven up will be a more general treatment in cancer I/O , a bit like
keytruda, started off with one target, being successful in that initial target
it is now accepted in multiple treatments......
Data needs to be good though, I'm looking forward to seeing the new data
on tacti-Mel....and aipac not far away.......I'm also a bit keen on seeing
"efti's" compatibility with peptides in cytlimic's research.....
Also we can't be far away from news with our collaboration with Monash Uni
re why "efti" works....If immutep can find that out, well, who knows but
it's got to be a positive...